After repeatedly wowing investors, Roche’s star eye med Vabysmo collected more than $4 billion in sales during its third year on the market. | After repeatedly wowing investors, Roche’s star eye med ...

Although Lonza posted slightly lower sales than analysts had expected in 2024, the Swiss CDMO suggested in its year-end report that it's in a stronger position going into 2025 thanks to improved ...

On 1 July 2025, the 100th anniversary of the CHF 100 gold Vreneli will be marked by the issuance of a commemorative coin. This special coin 100 Years 100-Franc Vreneli echoes the design and history of ...

The contraction in Swiss watch exports intensified in December with a decline of 5.4%, resulting in a total value of 2.0 billion Swiss francs ($2.21 billion), according to data from the Federation of ...

The industrial-technology company beat market views as its electrification business continued to benefit from data-center ...

The Swiss giant is planning to increase the capacity of production plants in Veracruz, Guanajuato, Querétaro and the State of ...

The watchmaker reported lower net sales for last year, as sales and market-share gains in the U.S., Japan, India and the ...

Skittish Chinese consumers at home or abroad dragged down the Swatch Group: The Swiss company’s 2024 net income dropped 75 percent to 219 million Swiss francs, or $242 million at current exchange ...

The Red Cross museum in Geneva is warning that it risks closure after its funding was axed in a broad government cost-cutting ...

Swatch Group reported sharply lower results for 2024. The prolonged slowdown of the watchmaking industry in China, the watchmaking group's largest market, and the strength of the Swiss franc continued ...

In the final month of 2024, exports of watches between 200 and 500 Swiss francs were the hardest hit, with a drop of 13.2 ...

Group sales grew by 7%1 at constant exchange rates (CER; 3% in CHF), driven by strong demand for both medicines and diagnostics.Excluding COVID-19, Group sales increased by 9%.